Clinical and immunohistochemical evaluation of psoriatic plaques treated with topical 5‐aminolaevulinic acid photodynamic therapy

Background/purpose: The aims of this study were to investigate the clinical and immunohistochemical events of psoriatic plaques during photodynamic therapy (PDT) using topical application of 5‐aminolaevulinic acid (ALA).

[1]  G. Carpenter,et al.  Visualization of epidermal growth factor receptors in human epidermis. , 1984, The Journal of investigative dermatology.

[2]  A. Cooper,et al.  The endothelium in psoriasis , 1995, The British journal of dermatology.

[3]  P. Kerkhof,et al.  Epidermal differentiation characteristics of the psoriatic plaque during treatment with calcipotriol , 1996, Archives of Dermatological Research.

[4]  J. Moore,et al.  Quantitative histological changes in murine tail skin following photodynamic therapy. , 1989, British Journal of Cancer.

[5]  CLAUDE C. FRAZIER,et al.  PHOTODYNAMIC THERAPY IN DERMATOLOGY , 1996, International journal of dermatology.

[6]  K. Svanberg,et al.  Superficial blood flow following photodynamic therapy of malignant non–melanoma skin tumours measured by laser Doppler perfusion imaging , 1997, The British journal of dermatology.

[7]  D. Ruiter,et al.  A new 180-kDa dermal endothelial cell activation antigen: in vitro and in situ characteristics. , 1993, The Journal of investigative dermatology.

[8]  J. Barker,et al.  Immunohistochemical evaluation of psoriatic plaques following selective photothermolysis of the superficial capillaries , 2001, British Journal of Dermatology.

[9]  H. Hönigsmann,et al.  Photodynamic therapy of epithelial skin tumours using delta‐aminolaevulinic acid and desferrioxamine , 1995, The British journal of dermatology.

[10]  W. Kennedy,et al.  Clinical and histologic evaluation of psoriatic plaques treated with a flashlamp pulsed dye laser. , 1996, Journal of the American Academy of Dermatology.

[11]  A. Ros,et al.  Psoriasis response to the pulsed dye laser , 1996, Lasers in Surgery and Medicine.

[12]  I. Braverman,et al.  The response of psoriatic epidermis and microvessels to treatment with topical steroids and oral methotrexate. , 1985, The Journal of investigative dermatology.

[13]  T. Ruzicka,et al.  Aminolevulinic acid: pharmacological profile and clinical indication , 2001, Expert opinion on investigational drugs.

[14]  W. Sterry,et al.  Treatment of psoriasis by topical photodynamic therapy with polychromatic light , 1994, The Lancet.

[15]  R. G. Statius van Eps,et al.  Photodynamic therapy of extracellular matrix stimulates endothelial cell growth by inactivation of matrix-associated transforming growth factor-beta. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[16]  Jean Kanitakis,et al.  Filaggrin expression in normal and pathological skin , 1988, Virchows Archiv A.

[17]  I. Braverman,et al.  Role of the microcirculation in the treatment and pathogenesis of psoriasis. , 1982, The Journal of investigative dermatology.

[18]  M. Stringer,et al.  The variable response of plaque psoriasis after a single treatment with topical 5‐aminolaevulinic acid photodynamic therapy , 1997, The British journal of dermatology.

[19]  K. König,et al.  Photodynamic therapy in psoriasis: suppression of cytokine production in vitro and recording of fluorescence modification during treatment in vivo , 2004, Archives of Dermatological Research.

[20]  I. Leigh,et al.  Keratins (K16 and K17) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro. , 1995, The British journal of dermatology.

[21]  L. Nanney,et al.  Altered [125I]epidermal growth factor binding and receptor distribution in psoriasis. , 1986, The Journal of investigative dermatology.

[22]  S. Schwartz,et al.  Inhibition of endothelial regeneration by type-beta transforming growth factor from platelets. , 1986, Science.

[23]  J. Kennedy,et al.  Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. , 1990, Journal of photochemistry and photobiology. B, Biology.

[24]  S. Ibbotson,et al.  UV-B phototherapy clears psoriasis through local effects. , 2002, Archives of dermatology.

[25]  P. Van Erp,et al.  Immunohistochemical assessment of keratin 16 on paraffin-embedded sections of normal and hyperproliferative skin: monoclonal antibodies Ks8.12 and LL025 in a comparative study , 1999, Archives of Dermatological Research.

[26]  G. Stables,et al.  Improved response of plaque psoriasis after multiple treatments with topical 5-aminolaevulinic acid photodynamic therapy. , 1999, Acta dermato-venereologica.

[27]  Irene M. Leigh,et al.  Keratins (Kl6 and Kl7) as markers of keratinocyte hyperproliferation in psoriasis in vivo and in vitro , 1995 .